Chengdu-based Clover Biopharmaceuticals has raised $230 million in Series C funding led by GL Ventures and Temasek Holdings. Oceanpine Capital, OrbiMed, and Delos Capital all re-upped.
The company claims to have received more than $400 million in funding over the past 12 months. Its Series B round - worth $43 million - was announced in 2019. Lapam Capital and Delos were the lead investors....
True North has agreed to sell India-based RDC Concrete, a company it has owned since 2005, to private equity-backed online construction marketplace Infra.market.
Freshworks, one of India's leading software-as-a-service (SaaS) businesses, traded strongly on its NASDAQ debut following a $1 billion IPO.
China-focused private equity firm FountainVest Partners has agreed to buy Ziwi, New Zealand’s leading exporter of pet food.